Advanced Renal Cell Carcinoma (aRCC)
Also known as: Advanced Renal Cell Cancer / Advanced Renal Cell Carcinoma (RCC) / Advanced Renal Cell Carcinoma / Adenocarcinoma of kidney / Renal cell cancer / Renal cell carcinoma stage unspecified / Grawitz tumor / Renal cell carcinoma NOS / Renal cell adenocarcinoma / Grawitz tumour / Renal cell carcinoma (disorder) / Renal cell carcinoma / Renal cell carcinoma (morphologic abnormality) / Carcinoma, Renal Cell / Clear cell carcinoma of kidney (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11945 | Avelumab | An anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma. |
| DB06626 | Axitinib | An oral VEGFR and kinase inhibitor used for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. |
| DB15463 | Belzutifan | An inhibitor of hypoxia-inducible factor 2α used as an antineoplastic in the treatment of certain cancers associated with von Hippel-Lindau (VHL) disease. |
| DB08875 | Cabozantinib | A tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. |
| DB09078 | Lenvatinib | A receptor tyrosine kinase inhibitor used for the treatment of metastatic thyroid cancer, advanced renal cell carcinoma in combination with everolimus, and unresectable hepatocellular carcinoma. |
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| DB06589 | Pazopanib | An antineoplastic agent used in the treatment of advanced renal cell cancer and advanced soft tissue sarcoma in patients with prior chemotherapy. |
| DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
| DB00398 | Sorafenib | A kinase inhibitor used to treat unresectable liver carcinoma, advanced renal carcinoma, and differentiated thyroid carcinoma. |
| DB06287 | Temsirolimus | A antineoplastic agent used in the treatment of renal cell carcinoma (RCC) that works by inhibiting mTOR. |
| DB11800 | Tivozanib | A kinase inhibitor to treat adult patients with renal cell carcinoma (RCC) who have failed prior systemic therapies or experienced relapsed disease. |